414
Participants
Start Date
February 26, 2025
Primary Completion Date
February 29, 2028
Study Completion Date
August 31, 2028
SIM0505 for injection
Every 21 days is one cycle. Multiple dose levels of SIM0505 will be explored in dose escalation, and determine the maximum tolerated dose.
SIM0505 for injection
Every 21 days is one cycle. 2-3 dose levels of SIM0505 will be explored in dose optimization, and determine the recommended dose (RD) of SIM0505 and evaluate the preliminary anti-tumor activity of SIM0505
RECRUITING
Sarah Cannon Research Institute (SCRI) - Lake Nona, Orlando
RECRUITING
Sarah Cannon Research Institute (SCRI) - Nashville, Nashville
RECRUITING
UT Health San Antonio - Mays Cancer Center, San Antonio
RECRUITING
The first medical center of PLA general hospital, Beijing
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
RECRUITING
Cancer Hospital of Shandong First Medical University, Jinan
RECRUITING
Affiliated Hospital of Jining Medical University, Jining
RECRUITING
HunanCancer Hospital, Changsha
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
RECRUITING
Hackensack University Medical Center, Hackensack
Lead Sponsor
Shanghai Xianxiang Medical Technology Co., Ltd.
INDUSTRY
NextCure, Inc.
INDUSTRY